Friday, December 5, 2025
Search

Franchise Group And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Franchise Group  And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - Franchise Group (FRG), First Solar (FSLR), Solar Capital Ltd. (SLRC) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Franchise Group (FRG)

59.3% sales growth and 6.1% return on equity

Franchise Group, Inc. operates as a retailer, franchisor operator, and acquirer of franchised and franchisable businesses.

Franchise Group's sales growth this year is expected to be 43.3% and 8.6% for next year.

Year-on-year quarterly revenue growth grew by 73.4%, now sitting on 2.64B for the twelve trailing months.

Volume

Today's last reported volume for Franchise Group is 140991 which is 28.48% below its average volume of 197135.

Franchise Group's sales growth for the next quarter is 59.3%. The company's growth estimates for the current quarter and the next is 433.3% and 88.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.1%.

Volatility

Franchise Group's last day, last week, and last month's current volatility was 3.30%, 4.20%, and 2.17%, respectively.

Franchise Group's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 6.08% (day), 6.08% (last week), and 4.08% (last month), respectively.

Franchise Group's Stock Yearly Top and Bottom Value

Franchise Group's stock is valued at $37.29 at 16:22 EST, way under its 52-week high of $41.50 and way higher than its 52-week low of $22.76.

Franchise Group's Moving Average

Franchise Group's value is above its 50-day moving average of $35.30 and above its 200-day moving average of $35.81.

2. First Solar (FSLR)

34.1% sales growth and 10.22% return on equity

First Solar, Inc. provides photovoltaic (PV) solar energy solutions in the United State, Japan, France, Canada, India, Australia, and internationally.

First Solar's sales growth this year is expected to be 7.9% and a negative 5.3% for next year.

Year-on-year quarterly revenue growth declined by 2.1%, now sitting on 2.97B for the twelve trailing months.

Volume

Today's last reported volume for First Solar is 1376050 which is 21.77% below its average volume of 1759200.

News about First Solar(FSLR) today

  • According to today's article on Business Insider, "Intersect Power, a clean energy company bringing innovative and scalable low-carbon solutions to its customers in retail and wholesale energy markets, today announced a memorandum of understanding (MOU) with Electric Hydrogen, an electrolyzer manufacturer led by a team of energy transition veterans from First Solar and Tesla, to advance green hydrogen production infrastructure. ", "Founded by ground-breaking renewable energy technologists from First Solar and Tesla, Electric Hydrogen (EH2) is taking learnings from scaling solar, energy storage and battery electric vehicles (BEVs) and putting them to work at the frontier of cleantech - decarbonizing the industrial sectors with green hydrogen powered by 100% renewable energy. "

First Solar's sales growth is a negative 0% for the ongoing quarter and 34.1% for the next. The company's growth estimates for the present quarter and the next is a negative 56.6% and negative -21.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.22%.

Volatility

First Solar's last day, last week, and last month's current volatility was 1.64%, 1.17%, and 3.01%, respectively.

First Solar's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.38% (day), 3.09% (last week), and 3.91% (last month), respectively.

First Solar's Stock Yearly Top and Bottom Value

First Solar's stock is valued at $95.01 at 16:22 EST, way below its 52-week high of $112.50 and way higher than its 52-week low of $67.71.

First Solar's Moving Average

First Solar's value is below its 50-day moving average of $96.35 and way above its 200-day moving average of $85.91.

3. Solar Capital Ltd. (SLRC)

20.3% sales growth and 9.02% return on equity

Solar Capital Ltd.

Solar Capital Ltd.'s sales growth this year is expected to be 19.5% and 8.4% for next year.

Year-on-year quarterly revenue growth grew by 24.3%, now sitting on 131.68M for the twelve trailing months.

Volume

Today's last reported volume for Solar Capital Ltd. is 94713 which is 25.02% below its average volume of 126321.

Solar Capital Ltd.'s sales growth for the next quarter is 20.3%. The company's growth estimates for the present quarter and the next is 8.8% and 11.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.02%.

Volatility

Solar Capital Ltd.'s last day, last week, and last month's current volatility was 0.94%, 0.98%, and 0.83%, respectively.

Solar Capital Ltd.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.25% (day), 1.27% (last week), and 1.67% (last month), respectively.

Solar Capital Ltd.'s Stock Yearly Top and Bottom Value

Solar Capital Ltd.'s stock is valued at $19.34 at 16:22 EST, under its 52-week high of $20.00 and way higher than its 52-week low of $15.40.

Solar Capital Ltd.'s Moving Average

Solar Capital Ltd.'s value is above its 50-day moving average of $19.12 and above its 200-day moving average of $18.87.

4. Federal Signal Corporation (FSS)

14.3% sales growth and 14.73% return on equity

Federal Signal Corporation, together with its subsidiaries, designs, manufactures, and supplies a suite of products and integrated solutions for municipal, governmental, industrial, and commercial customers in the United States, Canada, Europe, and internationally.

Federal Signal Corporation's sales growth this year is anticipated to be 13.3% and 8.9% for next year.

Year-on-year quarterly revenue growth grew by 23.9%, now sitting on 1.19B for the twelve trailing months.

Volume

Today's last reported volume for Federal Signal Corporation is 254570 which is 48.01% above its average volume of 171995.

Federal Signal Corporation's sales growth is a negative 0% for the ongoing quarter and 14.3% for the next. The company's growth estimates for the ongoing quarter and the next is 9.5% and 18.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.73%.

Volatility

Federal Signal Corporation's last day, last week, and last month's current volatility was 2.12%, 1.42%, and 1.38%, respectively.

Federal Signal Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.14% (day), 2.54% (last week), and 2.21% (last month), respectively.

Federal Signal Corporation's Stock Yearly Top and Bottom Value

Federal Signal Corporation's stock is valued at $39.44 at 16:22 EST, below its 52-week high of $43.77 and way higher than its 52-week low of $28.03.

Federal Signal Corporation's Moving Average

Federal Signal Corporation's worth is below its 50-day moving average of $39.57 and below its 200-day moving average of $40.02.

5. Collegium Pharmaceutical (COLL)

11.6% sales growth and 52.22% return on equity

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management.

Collegium Pharmaceutical's sales growth this year is anticipated to be 10% and 10.6% for next year.

Year-on-year quarterly revenue growth grew by 6.3%, now sitting on 326.11M for the twelve trailing months.

Volume

Today's last reported volume for Collegium Pharmaceutical is 178986 which is 39.8% below its average volume of 297366.

Collegium Pharmaceutical's sales growth is a negative 0% for the present quarter and 11.6% for the next. The company's growth estimates for the current quarter and the next is 200% and 395%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 52.22%.

Volatility

Collegium Pharmaceutical's last day, last week, and last month's current volatility was 0.31%, 0.96%, and 1.15%, respectively.

Collegium Pharmaceutical's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.01% (day), 3.11% (last week), and 2.78% (last month), respectively.

Collegium Pharmaceutical's Stock Yearly Top and Bottom Value

Collegium Pharmaceutical's stock is valued at $19.87 at 16:22 EST, way below its 52-week high of $26.91 and way above its 52-week low of $17.24.

Collegium Pharmaceutical's Moving Average

Collegium Pharmaceutical's worth is under its 50-day moving average of $20.13 and way under its 200-day moving average of $22.40.